Evidence map›Paper›PMID 34250413›Full record

ArticleJCO precision oncology2021

Molecular Tumor Board Guides Successful Treatment of a Rare, Locally Aggressive, Uterine Mesenchymal Neoplasm.

Elaine M Walsh, Deyin Xing, Melissa H Lippitt, Amanda N Fader, Stephanie L Wethington, Christian F Meyer, Stephanie L Gaillard

Abstract readCase Reports
In one paragraph

Article in JCO precision oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Targeted Treatment of Soft-Tissue Sarcoma.Journal of personalized medicine · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elaine M WalshDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD.
Deyin XingDepartment of Pathology, Johns Hopkins Hospital, Baltimore, MD.
Melissa H LippittDepartment of Gynecology and Obstetrics, Division of Gynecologic Oncology, Johns Hopkins Hospital, Baltimore, MD.
Amanda N FaderDepartment of Gynecology and Obstetrics, Division of Gynecologic Oncology, Johns Hopkins Hospital, Baltimore, MD.
Stephanie L WethingtonDepartment of Gynecology and Obstetrics, Division of Gynecologic Oncology, Johns Hopkins Hospital, Baltimore, MD.
Christian F MeyerDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD.
Stephanie L GaillardDepartment of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital, Baltimore, MD.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Precision Medicine For Pediatric Low-Grade GliomasR01NS091620 · NINDS · DANA-FARBER CANCER INST · PI HAAS-KOGAN, DAPHNE A., RESNICK, ADAM CAIN · 2015 to 2019
$2.6M
Pediatric low-grade gliomas: biology and molecular targeting.R01NS085336 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI RESNICK, ADAM CAIN · 2014 to 2018
$1.8M
NCI NIH HHS P30 CA008748NINDS NIH HHS R01 NS085336NINDS NIH HHS R01 NS091620
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FemaleHumansMiddle AgedNeoplasms, Connective and Soft TissueRare DiseasesTreatment OutcomeUterine Neoplasms

Identifiers

PMID34250413
PMCPMC8232830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.